The Pharmacy Times® Schizophrenia Resource Center is a comprehensive resource for clinical news and expert insights on treatments for schizophrenia.
August 15th 2025
CT-155, an investigational prescription digital therapeutic, was found to improve motivation, sociality, and other negative symptoms in patients with schizophrenia as an adjunct to antipsychotic treatment.
Use of Long-Acting Injectable Antipsychotic Medications in Schizophrenia Treatment
April 1st 2025Schizophrenia is a chronic mental illness that significantly affects patients through its symptoms, associated health conditions, and treatment challenges, with long-acting injectable antipsychotics offering potential benefits in improving adherence and reducing relapses.
Read More